Colgate-Palmolive Company (CL)
Why Colgate-Palmolive (CL) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Will Colgate's Innovation Drive Market Share Gains in 2025?
CL's innovation push spans premium oral, personal, home and pet care to drive market share growth in 2025 despite headwinds.
3 Bargain-Basement Dividend Stocks to Buy Now Before Their Discounts Disappear
Key Points in This Article: Consumer staple stocks provide stability due to consistent demand for essential goods, making them reliable investments in any market.
Colgate-Palmolive Company (CL) Q2 2025 Earnings Call Transcript
Colgate-Palmolive Company (NYSE:CL ) Q2 2025 Earnings Conference Call August 1, 2025 8:30 AM ET Company Participants John Faucher - Chief Investor Relations Officer and Executive VP of M&A Noel R. Wallace - Chairman, CEO & President Stanley J.
Colgate Tops Q2 Earnings & Sales Estimates, Tweaks Organic Sales View
CL beats Q2 earnings and sales estimates on pricing and organic growth but narrows the full-year organic sales view to the low end of the 2-4% range.
Nonfarm Payrolls Come in SIgnificantly Below Expectations
Nonfarm Payrolls Come in SIgnificantly Below Expectations.
Compared to Estimates, Colgate-Palmolive (CL) Q2 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Colgate-Palmolive (CL) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Colgate-Palmolive (CL) Q2 Earnings and Revenues Beat Estimates
Colgate-Palmolive (CL) came out with quarterly earnings of $0.92 per share, beating the Zacks Consensus Estimate of $0.89 per share. This compares to earnings of $0.91 per share a year ago.
Colgate Q2 Earnings: Do Productivity Initiatives Suggest a Beat?
CL's Q2 results are likely to reflect benefits from pricing, innovation and gross margin gains amid inflation and foreign exchange headwinds.
Countdown to Colgate-Palmolive (CL) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
Evaluate the expected performance of Colgate-Palmolive (CL) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Analysts Estimate Colgate-Palmolive (CL) to Report a Decline in Earnings: What to Look Out for
Colgate-Palmolive (CL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Colgate-Palmolive (CL) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
